Search research articles
Contact Us
Filters
Showing results (431-440 of 630) with videos related to
Page
of 63
Sort By:
Lasers in Surgery and Medicine
|
June 18, 2009
Trends in retinal damage thresholds from 100-millisecond near-infrared laser radiation exposures: a study at 1,110, 1,130, 1,150, and 1,319 nm
Rebecca L Vincelette, Benjamin A Rockwell, Jeff W Oliver, et al.
Haematologica
|
November 28, 2024
Identification of a clinicopathologic prognostic index for newly diagnosed large B-cell lymphoma patients treated with R-CHOP
Vincent Ni, Sunita D Nasta, Stefan K Barta, et al.
Microbiome
|
May 27, 2024
The interrelation between microbial immunoglobulin coating, vaginal microbiota, ethnicity, and preterm birth
H J Schuster, A C Breedveld, S P F Matamoros, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
May 15, 2001
Allogeneic cell therapy for patients who relapse after autologous stem cell transplantation
D L Porter, S M Luger, K M Duffy, et al.
The Journal of Biological Chemistry
|
November 10, 2000
Pescadillo, a novel cell cycle regulatory protein abnormally expressed in malignant cells
Y Kinoshita, A D Jarell, J M Flaman, et al.
EJNMMI Research
|
March 24, 2025
A biorthogonal chemistry approach for high-contrast antibody imaging of lymphoma at early time points
Swarbhanu Sarkar, Jonathan M Pham, Kimberly J Edwards, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 13, 2013
Malignant transformation of CD4+ T lymphocytes mediated by oncogenic kinase NPM/ALK recapitulates IL-2-induced cell signaling and gene expression reprogramming
Michal Marzec, Krzysztof Halasa, Xiaobin Liu, et al.
Leukemia & Lymphoma
|
December 10, 2020
Outcomes of patients with up to 6 years of follow-up from a phase 2 study of idelalisib for relapsed indolent lymphomas
Nina D Wagner-Johnston, Stephen J Schuster, Sven deVos, et al.
Blood
|
May 13, 2006
Mantle cell lymphoma cells express predominantly cyclin D1a isoform and are highly sensitive to selective inhibition of CDK4 kinase activity
Michal Marzec, Monika Kasprzycka, Raymond Lai, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 20, 2009
Humanized anti-CD20 antibody, veltuzumab, in refractory/recurrent non-Hodgkin's lymphoma: phase I/II results
Franck Morschhauser, John P Leonard, Luis Fayad, et al.
Page
of 63
Search research articles
Search
Showing results (431-440 of 630) with videos related to
Sort By:
Page
of 63
Lasers in Surgery and Medicine
|
June 18, 2009
Trends in retinal damage thresholds from 100-millisecond near-infrared laser radiation exposures: a study at 1,110, 1,130, 1,150, and 1,319 nm
Rebecca L Vincelette, Benjamin A Rockwell, Jeff W Oliver, et al.
Haematologica
|
November 28, 2024
Identification of a clinicopathologic prognostic index for newly diagnosed large B-cell lymphoma patients treated with R-CHOP
Vincent Ni, Sunita D Nasta, Stefan K Barta, et al.
Microbiome
|
May 27, 2024
The interrelation between microbial immunoglobulin coating, vaginal microbiota, ethnicity, and preterm birth
H J Schuster, A C Breedveld, S P F Matamoros, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
May 15, 2001
Allogeneic cell therapy for patients who relapse after autologous stem cell transplantation
D L Porter, S M Luger, K M Duffy, et al.
The Journal of Biological Chemistry
|
November 10, 2000
Pescadillo, a novel cell cycle regulatory protein abnormally expressed in malignant cells
Y Kinoshita, A D Jarell, J M Flaman, et al.
EJNMMI Research
|
March 24, 2025
A biorthogonal chemistry approach for high-contrast antibody imaging of lymphoma at early time points
Swarbhanu Sarkar, Jonathan M Pham, Kimberly J Edwards, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 13, 2013
Malignant transformation of CD4+ T lymphocytes mediated by oncogenic kinase NPM/ALK recapitulates IL-2-induced cell signaling and gene expression reprogramming
Michal Marzec, Krzysztof Halasa, Xiaobin Liu, et al.
Leukemia & Lymphoma
|
December 10, 2020
Outcomes of patients with up to 6 years of follow-up from a phase 2 study of idelalisib for relapsed indolent lymphomas
Nina D Wagner-Johnston, Stephen J Schuster, Sven deVos, et al.
Blood
|
May 13, 2006
Mantle cell lymphoma cells express predominantly cyclin D1a isoform and are highly sensitive to selective inhibition of CDK4 kinase activity
Michal Marzec, Monika Kasprzycka, Raymond Lai, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 20, 2009
Humanized anti-CD20 antibody, veltuzumab, in refractory/recurrent non-Hodgkin's lymphoma: phase I/II results
Franck Morschhauser, John P Leonard, Luis Fayad, et al.
Page
of 63